BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III Romania
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2014
At a glance
- Drugs Sirolimus (Primary)
- Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms BIOFLOW-III Romania
- Sponsors BIOTRONIK
- 25 Apr 2014 Trial status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Apr 2013 Planned number of patients changed from 600 to 450 as reported by ClinicalTrials.gov.
- 21 Aug 2012 New trial record